GET THE APP

Journal of Leukemia

Journal of Leukemia
Open Access

ISSN: 2329-6917

+44 1300 500008

Journal of Leukemia : Citations & Metrics Report

Articles published in Journal of Leukemia have been cited by esteemed scholars and scientists all around the world. Journal of Leukemia has got h-index 11, which means every article in Journal of Leukemia has got 11 average citations.

Following are the list of articles that have cited the articles published in Journal of Leukemia.

  2021 2020 2019 2018 2017 2016

Year wise published articles

62 23 11 8 22 23

Year wise citations received

54 59 64 98 109 74
Journal total citations count 618
Journal impact factor 2.11
Journal 5 years impact factor 3.71
Journal cite score 3.91
Journal h-index 11
Journal h-index since 2018 8
Important citations (462)

Design, synthesis and investigation of the mechanism of action underlying anti-leukemic effects of the quinolinequinones as ly83583 analogs

Differential gene expression changes and their implication on the disease progression in patients with chronic myeloid leukemia

Clinical implications of conventional cytogenetics, fluorescence in situ hybridization (fish) and molecular testing in chronic myeloid leukaemia patients in the tyrosine kinase inhibitor era – a review

Primary breast lymphoma – a case report

Wilms’ tumor gene (wt1) expression levels as prognostic marker in pediatric acute lymphoblastic leukemia

Serum vascular endothelial gowth factor correlates with hasford score in chronic myeloid leukemia

Association of haematological malignancies

Il-17 a and il-17 f single nucleotide polymorphisms and acute myeloid leukemia susceptibility and response to induction therapy in egypt

Prognostic value of interleukin-17 a gene polymorphism and serum il-17 levels in adult acute myeloid leukaemia patients

Prognostic value of interleukin-17 a gene polymorphism and serum il-17 levels in adult acute myeloid leukaemia patients

Improving therapy programs acute lymphoblastic leukemia in children: emphasis on minimal residual disease

Prospects for assessing the minimum residual disease in the post-induction period in b-linear acute lymphoblastic leukemia in children

Improvement of acute lymphoblastic leukemia therapy programs in children: focus on minimum residual disease

Clinical reasoning: a 59-year-old woman presenting with diplopia, dysarthria, right-sided weakness, and encephalopathy

Acute monocytic leukemia presenting as generalized lymphadenopathy and skin rash in a toddler: highlighting the clinicopathologic mimics

A narrative review of central nervous system involvement in acute leukemias

Behera p. research and reviews: journal of microbiology and biotechnology.

Jung h, kim jy, kim kb, chae yc, hahn y, kim jw, seo sb. deacetylase activity-independent transcriptional activation by hdac2 during tpa-induced hl-60 cell differentiation. plos one. 2018 aug 24;13(8):e0202935.

Dancing partners at the ball: rational selection of next generation anti-cd20 antibodies for combination therapy of chronic lymphocytic leukemia in the novel agents era

gv rr. types of cancer and surgery in rats (rattus norvegicus). growth.;91:95.

Top